Clinicopathologic significance of BubR1 and Mad2 overexpression in oral cancer

Oral Diseases

Volumn 21, Issue 6, 2015, Pages 713-720

  Teixeira, J H ^a   Silva, P M A ^a,b   Faria, J ^a   Ferreira, I ^a   Duarte, P ^a   Delgado, M L ^a   Queiros O ^a,c   Moreira, R ^a,c   Barbosa, J ^a   Lopes, C A ^d   do Amaral, J B ^e   Monteiro, L S ^a   Bousbaa, H ^a,d,f  

^a INSTITUTO DE INVESTIGAÇÃO E FORMAÇÃO AVANÇADA EM CIÊNCIAS E TECNOLOGIAS DA SAÚDE   (Portugal)

^b UNIVERSITY OF ALGARVE   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

^e HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^f UNIVERSITY OF PORTO   (Portugal)

Author keywords

BubR1; Mad2; Oral cancer; Prognosis; Proliferation; Spindle assembly checkpoint

Indexed keywords

BUB1 RELATED PROTEIN; KI 67 ANTIGEN; PROTEIN MAD2; BUB1 PROTEIN, HUMAN; MAD2L1 PROTEIN, HUMAN; MESSENGER RNA; PROTEIN SERINE THREONINE KINASE;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CHEEK MUCOSA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENDER; GENE OVEREXPRESSION; GINGIVA; HARD PALATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LABELING INDEX; LIP CANCER; M PHASE CELL CYCLE CHECKPOINT; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MOUTH SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TONGUE CANCER; CHEMISTRY; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR CELL LINE;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; HUMANS; KERATINOCYTES; M PHASE CELL CYCLE CHECKPOINTS; MAD2 PROTEINS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; SURVIVAL RATE;

EID: 84938738610     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12335     Document Type: Article

References (38)

1. Ando K, Kakeji Y, Kitao H et al (2010). High expression of BUBR1 is one of the factors for inducing DNA aneuploidy and progression in gastric cancer. Cancer Sci 101: 639-645.
2. Barbosa J, Nascimento AV, Faria J, Silva P, Bousbaa H (2011). The spindle assembly checkpoint: perspectives in tumorigenesis and cancer therapy. Front Biol 6: 147-155.
3. Bargiela-Iparraguirre J, Prado-Marchal L, Pajuelo-Lozano N, Jiménez B, Perona R, Sánchez-Pérez I (2014). Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells. Cell Cycle 13: 3590-3601.
4. Barnes L, Everson JW, Reichart P, Sidransky D (2005). World health organization classification of tumors: pathology and genetics of head and neck tumours. IARC Press: Lyon, pp. 164-175.
5. Bharadwaj R, Yu H (2004). The spindle checkpoint, aneuploidy, and cancer. Oncogene 23: 2016-2027.
6. Bockmuhl U, Petersen I (2002). DNA ploidy and chromosomal alterations in head and neck squamous cell carcinoma. Virchows Arch 441: 541-550.
7. Burum-Auensen E, De Angelis PM, Schjolberg AR, Kravik KL, Aure M, Clausen OPF (2007a). Subcellular localization of the spindle proteins Aurora A, Mad2, and BUBR1 assessed by immunohistochemistry. J Histochem Cytochem 55: 477-486.
8. Burum-Auensen E, Deangelis PM, Schjolberg AR, Roislien J, Andersen SN, Clausen OPF (2007b). Spindle proteins Aurora A and BUB1B, but not Mad2, are aberrantly expressed in dysplastic mucosa of patients with longstanding ulcerative colitis. J Clin Pathol 60: 1403-1408.
9. Carlos de Vicente J, Herrero-Zapatero A, Fresno MF, Lopez-Arranz JS (2002). Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance. Oral Oncol 38: 301-308.
10. Dobles M, Liberal V, Scott ML, Benezra R, Sorger PK (2000). Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell 101: 635-645.
11. Gascoigne KE, Taylor SS (2008). Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14: 111-122.
12. Greene LM, Campiani G, Lawler M, Williams DC, Zisterer DM (2008). BubR1 is required for a sustained mitotic spindle checkpoint arrest in human cancer cells treated with tubulin-targeting pyrrolo-1, 5-benzoxazepines. Mol Pharmacol 73: 419-430.
13. Hao X, Zhou Z, Ye S et al (2010). Effect of Mad2 on paclitaxel-induced cell death in ovarian cancer cells. J Huazhong Univ Sci Technolog Med Sci 30: 620-625.
14. Hsieh PC, Chen YK, Tsai KB et al (2010). Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109: 257-267.
15. Janssen A, Kops GJPL, Medema RH (2009). Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells. Proc Natl Acad Sci U S A 106: 19108-19113.
16. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011). Global cancer statistics. CA Cancer J Clin 61: 69-90.
17. Kato T, Daigo Y, Aragaki M et al (2011). Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients. Lung Cancer 74: 124-131.
18. Lee EA, Keutmann MK, Dowling ML, Harris E, Chan G, Kao GD (2004). Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells. Mol Cancer Ther 3: 661-669.
19. Lengauer C, Kinzler KW, Vogelstein B (1998). Genetic instabilities in human cancers. Nature 396: 643-649.
20. Ling Y, Zhang X, Bai Y et al (2014). Overexpression of Mps1 in colon cancer cells attenuates the spindle assembly checkpoint and increases aneuploidy. Biochem Biophys Res Commun 450: 1690-1695.
21. Lira RC, Miranda FA, Guimaraes MC et al (2010). BUBR1 expression in benign oral lesions and squamous cell carcinomas: correlation with human papillomavirus. Oncol Rep 23: 1027-1036.
22. Logarinho E, Bousbaa H (2008). Kinetochore-microtubule interactions "in check" by Bub1, Bub3 and BubR1: The dual task of attaching and signalling. Cell Cycle 7: 1763-1768.
23. McGrogan B, Phelan S, Fitzpatrick P et al (2014). Spindle assembly checkpoint protein expression correlates with cellular proliferation and shorter time to recurrence in ovarian cancer. Hum Pathol 45: 1509-1519.
24. Moura IMB, Delgado ML, Silva PMA et al (2014). High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma. J Oral Pathol Med 43: 225-231.
25. Neville BW, Day TA (2002). Oral cancer and precancerous lesions. CA Cancer J Clin 52: 195-215.
26. Rizzardi C, Torelli L, Barresi E et al (2011). BUBR1 expression in oral squamous cell carcinoma and its relationship to tumor stage and survival. Head Neck 33: 727-733.
27. Rizzardi C, Torelli L, Schneider M et al (2014). MAD2 expression in oral squamous cell carcinoma and its relationship to tumor grade and proliferation. Anticancer Res 34: 7021-7027.
28. Saunders WS, Shuster M, Huang X et al (2000). Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci U S A 97: 303-308.
29. Schmittgen TD, Livak KJ (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
30. Silva P, Barbosa J, Nascimento AV, Faria J, Reis R, Bousbaa H (2011). Monitoring the fidelity of mitotic chromosome segregation by the spindle assembly checkpoint. Cell Prolif 44: 391-400.
31. Silva PMA, Reis RM, Bolanos-Garcia VM, Florindo C, Tavares AA, Bousbaa H (2014). Dynein-dependent transport of spindle assembly checkpoint proteins off kinetochores toward spindle poles. FEBS Lett 588: 3265-3273.
32. Sotillo R, Hernando E, Diaz-Rodriguez E et al (2007). Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11: 9-23.
33. Sudakin V, Chan GK, Yen TJ (2001). Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J Cell Biol 154: 925-936.
34. Sudo T, Nitta M, Saya H, Ueno NT (2004). Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint. Cancer Res 64: 2502-2508.
35. Teixeira JH, Silva PM, Reis RM et al (2014). An overview of the spindle assembly checkpoint status in oral cancer. Biomed Res Int 2014: 145289.
36. Wang LG, Liu XM, Kreis W, Budman DR (1999). The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Cancer Chemother Pharmacol 44: 355-361.
37. Yamamoto Y, Matsuyama H, Chochi Y et al (2007). Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer. Cancer Genet Cytogenet 174: 42-47.
38. Zhao J, Liu S, Wang H et al (2011). Mitotic arrest deficient protein MAD2B is overexpressed in human glioma, with depletion enhancing sensitivity to ionizing radiation. J Clin Neurosci 18: 827-833.